Biomarker analysis: Multi-omics elucidation of Cohort 1 from a phase II study of a triple combination of Atezolizumab plus cobimetinib plus eribulin in patients with metastatic inflammatory breast cancerBora Lim,Angela Alexander,Jie S. Willey,Huiming Sun,Suyu Liu,Anisha B. Patel,Edwin Roger Parra,Cara Haymaker,Luisa Solis Soto,Alejandra Serrano,Baohua Sun,Cibelle Freitas Pinto Lima,Auriole Tamegnon,Renganayaki K. Pandurengan,Dzifa Douse, Jessica Lan,Luthra Raja,Randy Chu,Mark Knafl,Scott E. Woodman,Haifeng Zhu,Katja Shulze, Katherine Fedenko,Walter Darbonne,Naoto T. Ueno,Vicente ValeroCANCER RESEARCH(2023)引用 0|浏览42暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要